Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
In May 1992, the Connecticut legislature passed new laws aimed at increasing injecting drug users' (IDUs) access to sterile needles and syringes (syringes); as of July 1992, pharmacists were permitted to sell and individuals were permitted to possess up to 10 syringes without medical prescriptions (nonprescription syringes). We evaluated the impact of the new laws by conducting (1) prospective surveillance of syringe sales and policies at selected community pharmacies (pharmacies) and (2) a telephone survey of pharmacy managers' reports of syringe sales and policies at a statewide stratified random sample of pharmacies. Our data provide direct evidence that most, but not all, Connecticut pharmacies sold nonprescription syringes when permitted to do so by the new laws. For example, using the telephone survey data, we estimate that during November, 1993, 83% [95% CI: 77-89%] of all Connecticut pharmacies sold nonprescription syringes and 56,000 [95% CI: 44,000-68,000] nonprescription syringes were sold, during November 1993. Our data provide indirect evidence that IDUs were purchasing nonprescription syringes at pharmacies. For example, in five Hartford pharmacies located in neighborhoods where injection drug use was prevalent, the total number of nonprescription syringes sold per month increased significantly from 460 in July 1992 to 2,482 in June 1993 (p = 0.0001). The data suggest that the new laws increased IDUs' access to sterile syringes in Connecticut.
Valleroy
L A
LA
HIV Seroepidemiology Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Weinstein
B
B
Jones
T S
TS
Groseclose
S L
SL
Rolfs
R T
RT
Kassler
W J
WJ
D002487:Centers for Disease Control and Prevention, U.S.; D003237:Connecticut; D003416:Criminal Law; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007407:Interviews as Topic; D010594:Pharmacies; D011358:Product Surveillance, Postmarketing; D011446:Prospective Studies; D013219:State Government; D015819:Substance Abuse, Intravenous / Q000150:complications*; D013594:Syringes; D013689:Telephone; D014481:United States